BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846
67 results:

  • 1. [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
    Li ZM; Liang ZH; Liu N; Wei KR
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):232-238. PubMed ID: 38494769
    [No Abstract]    [Full Text] [Related]  

  • 2. [cancer incidence and mortality in China, 2022].
    Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
    [No Abstract]    [Full Text] [Related]  

  • 3. Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma.
    Gao Z; An P; Li R; Wu F; Sun Y; Wu J; Yang G; Wang Z
    Cancer Imaging; 2024 Feb; 24(1):25. PubMed ID: 38336821
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The predictive value of the thyroid nodule benign and malignant based on the ultrasound nodule-to-muscle gray-scale ratio.
    Hu T; Zhou T; Zhang Y; Zhou L; Huang X; Cai Y; Qian S; Huang K; Luo D
    J Clin Ultrasound; 2024 Jan; 52(1):51-58. PubMed ID: 37915163
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anthropometric, dietary, and lifestyle factors and risk of advanced thyroid cancer: The NIH-AARP diet and health cohort study.
    Greca A; Grau L; Arbet J; Liao LM; Sosa JA; Haugen BR; Kitahara CM
    Clin Endocrinol (Oxf); 2023 Dec; 99(6):586-597. PubMed ID: 37694684
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Second Primary cancer Among Patients With Papillary thyroid Carcinoma Following the Chernobyl Disaster.
    Taha A; Taha-Mehlitz S; Nadyrov EA; Zinovkin D; Veyalkin I; Levin L; Pranjol MZI; Melling N; Honaker MD; Cattin PC; Schmid RA
    JAMA Netw Open; 2023 Aug; 6(8):e2329559. PubMed ID: 37589974
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects.
    Iwamoto Y; Kimura T; Dan K; Ohnishi M; Takenouchi H; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Shimoda M; Nakanishi S; Mune T; Kaku K; Kaneto H
    Front Endocrinol (Lausanne); 2023; 14():1221723. PubMed ID: 37583431
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Establishment and validation of a nomogram model for evaluating the metastasis of lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma].
    Wang ZY; Chang QG; Guo HH; Du X; Liu YH; Yin DT
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(28):2175-2182. PubMed ID: 37482730
    [No Abstract]    [Full Text] [Related]  

  • 9. Prognostic factors in radiotherapy of anaplastic thyroid carcinoma: a single center study over 31 years.
    Jacob J; Vordermark D; Lorenz K; Medenwald D
    Radiat Oncol; 2023 Apr; 18(1):71. PubMed ID: 37076888
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Association of extranodal extension and lymph node ratio with radioactive iodine-refractory papillary thyroid cancer].
    Luo ZY; Qin JW; Fang JG; Zheng C; Gong WB; Hei H
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3856-3861. PubMed ID: 36540923
    [No Abstract]    [Full Text] [Related]  

  • 11. NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology.
    Agaimy A; Brcic L; Briski LM; Hung YP; Michal M; Michal M; Nielsen GP; Stoehr R; Rosenberg AE
    Genes Chromosomes Cancer; 2023 May; 62(5):256-266. PubMed ID: 36524687
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dyslipidemia Risk in thyroid cancer Patients: A Nationwide Population-Based Cohort Study.
    Song Y; Lee HS; Park G; Kang SW; Lee JW
    Front Endocrinol (Lausanne); 2022; 13():893461. PubMed ID: 35832430
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience.
    Wei B; Zhao T; Shen H; Jin M; Zhou Q; Liu X; Wang J; Wang Q
    Ann Surg Oncol; 2022 Feb; 29(2):1208-1215. PubMed ID: 34694522
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Health management and care following the Fukushima nuclear power plant accident: overview of Fukushima Health Management Survey.
    Kamiya K
    Ann ICRP; 2021 Jul; 50(1_suppl):82-89. PubMed ID: 34218678
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy and Safety of Thermal Ablation for Treatment of Solitary T1N0M0 Papillary thyroid Carcinoma: A Multicenter Retrospective Study.
    Cao XJ; Wang SR; Che Y; Liu J; Cong ZB; He JF; Wang HL; Liu G; Guo JQ; Hao Y; Wang ZH; Zhou Y; Jian M; Shi LL; Qi L; Zhu YL; Wang X; Yan GZ; Shataer A; Liu XF; Wei Y; Zhao ZL; Peng LL; Li Y; Yu MA
    Radiology; 2021 Jul; 300(1):209-216. PubMed ID: 33904775
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Stimulated serum thyroglobulin but not RAIU level is a prognostic factor for ablation efficacy with a 3.7GBq (100mCi) fixed
    Xiao L; Wang Y; Huang R; Li L
    Hell J Nucl Med; 2021; 24(1):53-59. PubMed ID: 33866339
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognosis of papillary thyroid carcinoma in relation to preoperative subclinical hypothyroidism.
    Kang SY; Ahn HR; Youn HJ; Jung SH
    Ann R Coll Surg Engl; 2021 May; 103(5):367-373. PubMed ID: 33682437
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary thyroid cancer.
    Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
    Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Lymphovascular invasion of papillary thyroid carcinoma revisited in the era of active surveillance.
    Cheng SP; Lee JJ; Chien MN; Kuo CY; Jhuang JY; Liu CL
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1814-1819. PubMed ID: 32732093
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment.
    Fugazzola L; Di Stefano M; Censi S; Repaci A; Colombo C; Grimaldi F; Magri F; Pagotto U; Iacobone M; Persani L; Mian C
    J Endocrinol Invest; 2021 Mar; 44(3):587-597. PubMed ID: 32656666
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.